Corcept Therapeutics made required filings with the SEC regarding institutional holdings on June 16, 2026.

The entities involved

• Corcept Therapeutics →

  American pharmaceutical company

  Nothing else this week.

• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12
• Securities and Exchange Commission →

  government agency of the Philippines

  • BlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Mon 16:42
  • Filing required regarding institutional holdings for Schwab Emerging Markets Equity ETF and Waterford Advisors LLC with the SEC.Mon 16:38

Related events

• Corcept Therapeutics disclosed insider trading activity via SEC filings.Sep 4
• Investor activity regarding Corcept Therapeutics, including RBC boosting holdings and Amundi buying, was disclosed via SEC filings.Aug 26
• Celcuity Inc. and Corcept Therapeutics are noted for developing targeted therapies in the United States.Jun 8
• Kiniksa Pharmaceuticals International filed required documents with the SEC regarding institutional investment activity.Sep 11
• Required regulatory filings regarding institutional holdings were made by Gilead Sciences, Inc. with the Securities and Exchange Commission on June 11, 2026.Jun 11